These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3871382)

  • 1. Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibition.
    Barry AL; Jones RN; Thornsberry C
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):7-17. PubMed ID: 3871382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
    Quentin C; Sageaux JC; Bebear C; Latrille J
    Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacteriostatic activity of apalcillin on Gram-negative bacilli and strict anaerobic bacteria. Multicenter study].
    Quentin C; Auzerie J; Bebear C; Acar JF; Kitzis MD; Avril JL; Moillo-Batt A; Shacoori Z; Bergogne-Berezin E; Joly-Guillou ML
    Pathol Biol (Paris); 1984 May; 32(5):301-6. PubMed ID: 6429608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.
    Jacobs MR; Aronoff SC; Johenning S; Shlaes DM; Yamabe S
    Antimicrob Agents Chemother; 1986 Jun; 29(6):980-5. PubMed ID: 3015017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads.
    Jacobs MR; Aronoff SC; Johenning S; Yamabe S
    J Antimicrob Chemother; 1986 Aug; 18(2):177-84. PubMed ID: 3019984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
    Machka K; Dickert H; Braveny I
    Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activities of cefpiramide and apalcillin individually and in combination.
    Allan JD; Eliopoulos GM; Ferraro MJ; Moellering RC
    Antimicrob Agents Chemother; 1985 May; 27(5):782-90. PubMed ID: 3925875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of ticarcillin, piperacillin, azlocillin and mezlocillin.
    Chattopadhyay B; Hall I; Curnow SR
    Curr Med Res Opin; 1983; 8(8):577-81. PubMed ID: 6653135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activities of apalcillin and piperacillin against gram-negative bacilli.
    Fass RJ; Helsel VL
    Antimicrob Agents Chemother; 1984 Nov; 26(5):660-4. PubMed ID: 6440476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibacterial activity of apalcillin against 300 strains of enterobacteria].
    Coulet M; Forey F; Brun Y; Fleurette J
    Pathol Biol (Paris); 1983 May; 31(5):311-8. PubMed ID: 6353323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics.
    Greenwood D; Eley A
    J Infect Dis; 1982 Jan; 145(1):110-7. PubMed ID: 6459389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity of apalcillin (PC-904) against gram-negative bacilli, especially ampicillin-, carbenicillin-, and gentamicin-resistant clinical isolates.
    Noguchi H; Kubo M; Kurashige S; Mitsuhashi S
    Antimicrob Agents Chemother; 1978 May; 13(5):745-52. PubMed ID: 248269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
    Eliopoulos GM; Moellering RC
    Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centers.
    Barry AL; Jones RN; Ayers LW; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1984 May; 25(5):669-71. PubMed ID: 6732234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity of apalcillin alone and combined with Ro 48-1220, a novel penam beta-lactamase inhibitor.
    Jones RN; Johnson DM
    Clin Microbiol Infect; 1995 Feb; 1(2):86-100. PubMed ID: 11866735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigations on antibacterial activity of apalcillin].
    Stille W; Helm E; Mielenz H
    Arzneimittelforschung; 1982; 32(9):1128-30. PubMed ID: 6816250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of apalcillin against Pseudomonas aeruginosa.
    Hollick GE; Gundrum J; Venezia RA
    Antimicrob Agents Chemother; 1984 Sep; 26(3):408-9. PubMed ID: 6439115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci.
    Thabaut A; Durosoir JL; Saliou P
    Infection; 1982; 10 Suppl 3():S249-56. PubMed ID: 7152690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative in vitro activity of 5 semi-synthetic penicillins against aerobic Gram-negative bacilli and enterococci (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):318-23. PubMed ID: 6460967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.